Almonertinib Mesilate Tablets

Ametinib mesylate tablets are an anti-tumor drug for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have experienced disease progression during or after treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and have been confirmed to have EGFR T790M mutations.
Ametinib mesylate is a kinase inhibitor of EGFR, which has anti-tumor effects on non-small cell lung cancer cell lines carrying EGFR mutations (T790M/L858R and Del19), and has a weak inhibitory effect on wild-type EGFR.